WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Linda GraisDirector2023-05-1510,000$2.45
$24.50kBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.16%6,943,654$10.07MInsider
Peter A. Thompson14.16%6,943,654$10.07MInsider
Orbimed Advisors LLC14.16%6,943,654$10.07MInstitution
Ecor1 Capital LLC10.53%5,162,154$7.49MInsider
Terry P. Gould6.94%3,402,422$4.93MInsider
Adams Street Partners LLC6.94%3,402,422$4.93MInsider
Adams Street Partners LLC6.68%3,275,616$4.75MInstitution
Samlyn Capital LLC5.09%2,496,259$3.62MInstitution
Richard A. Md Miller3.11%1,525,833$2.21MInsider
Holdings A. Novo2.83%1,389,498$2.01MInsider

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS39.12%60.38%Net Buying
LVTX22.20%0.00%
ENTX11.45%3.79%Net Buying
ANEB24.84%75.16%
CVM12.96%43.81%Net BuyingNet Buying

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 39.12% institutional shareholders, 60.38% Corvus Pharmaceuticals insiders, and 0.50% retail investors. Orbimed Advisors LLC is the largest individual Corvus Pharmaceuticals shareholder, owning 6.94M shares representing 14.16% of the company. Orbimed Advisors LLC's Corvus Pharmaceuticals shares are currently valued at $10.07M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.